title: TMP/SMX is still the preferred empiric antibiotic for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in the HIV population.
authors.forename: Gina M
authors.initials: GM
authors.lastname: Simoncini
authors.forename: Homayoon
authors.initials: H
authors.lastname: Khanlou
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects* / Q000276:immunology; D018461:Soft Tissue Infections / Q000188:drug therapy*; D013207:Staphylococcal Skin Infections / Q000188:drug therapy*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
chemical_list: D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination